Reporte zur Charge UJ8788A

Symptomtext

A pregnant patient was administered Fluzone QIV with no reported AE; Initial information received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult female patient who was pregnant and who got INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] with no reported adverse event. The gestation period at onset was not reported. The date of last menstrual period was not reported. The estimated due date was not reported. The actual date of delivery was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancies. On 27-Oct-2022, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE lot UJ8788A expiry date of 30-jun-2023 via unknown route in the left deltoid for Immunization. On 27-OCT-2022 the patient who was pregnant was administered fluzone qiv with no reported ae (maternal exposure timing unspecified) following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event a pregnant patient was administered fluzone qiv with no reported ae. Additionally, at time of reporting, the outcome of the pregnancy is unknown.